CARDLYTICS INC (CDLX)
US14161W1053 - Common Stock
We assign a fundamental rating of 3 out of 10 to CDLX. CDLX was compared to 96 industry peers in the Media industry. CDLX may be in some trouble as it scores bad on both profitability and health. CDLX is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CDLX had negative earnings in the past year.
CDLX had a negative operating cash flow in the past year.
In the past 5 years CDLX always reported negative net income.
In the past 5 years CDLX reported 4 times negative operating cash flow.
1.2 Ratios
The Return On Assets of CDLX (-30.33%) is worse than 86.32% of its industry peers.
The Return On Equity of CDLX (-86.67%) is worse than 76.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.33% | ||
| ROE | -86.67% | ||
| ROIC | N/A |
ROA(3y)-33.65%
ROA(5y)-24.34%
ROE(3y)-112.81%
ROE(5y)-77.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of CDLX (52.72%) is better than 65.26% of its industry peers.
In the last couple of years the Gross Margin of CDLX has grown nicely.
The Profit Margin and Operating Margin are not available for CDLX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.72% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.57%
GM growth 5Y2.94%
2. Health
2.1 Basic Checks
CDLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CDLX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CDLX has been increased compared to 5 years ago.
The debt/assets ratio for CDLX is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -1.92, we must say that CDLX is in the distress zone and has some risk of bankruptcy.
CDLX has a worse Altman-Z score (-1.92) than 82.11% of its industry peers.
CDLX has a Debt/Equity ratio of 1.30. This is a high value indicating a heavy dependency on external financing.
CDLX has a worse Debt to Equity ratio (1.30) than 67.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.92 |
ROIC/WACCN/A
WACC6.24%
2.3 Liquidity
CDLX has a Current Ratio of 2.13. This indicates that CDLX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CDLX (2.13) is better than 73.68% of its industry peers.
A Quick Ratio of 2.13 indicates that CDLX has no problem at all paying its short term obligations.
CDLX has a better Quick ratio (2.13) than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.13 |
3. Growth
3.1 Past
CDLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.35%, which is quite impressive.
CDLX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.95%.
Measured over the past years, CDLX shows a quite strong growth in Revenue. The Revenue has been growing by 15.46% on average per year.
EPS 1Y (TTM)89.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q64%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y18.27%
Revenue growth 5Y15.46%
Revenue growth Q2Q5.09%
3.2 Future
CDLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 84.39% yearly.
CDLX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.35% yearly.
EPS Next Y130%
EPS Next 2Y84.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.73%
Revenue Next 2Y11.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CDLX. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 18.47 indicates a rather expensive valuation of CDLX.
The rest of the industry has a similar Price/Forward Earnings ratio as CDLX.
CDLX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.47 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDLX's earnings are expected to grow with 84.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.39%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CDLX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CARDLYTICS INC
NASDAQ:CDLX (5/17/2024, 7:00:03 PM)
After market: 8.81 +0.02 (+0.23%)8.79
-0.48 (-5.18%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap423.41M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.47 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.33% | ||
| ROE | -86.67% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.72% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.3 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.13 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)89.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y130%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.95%
Revenue growth 3Y18.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y